Pressured by patients, FDA reviews ALS drug with modest data

25 March 2022 - The FDA meets next week to review a closely watched drug for ALS, or Lou Gehrig’s ...

Read more →

Mentoring as a potential means to assist consumer representatives contribute effectively to the assessment of health technologies in Australia: a pragmatic review

7 February 2022 - This project was implemented on behalf of the Health Technology Assessment Consumer Consultative Committee to explore training ...

Read more →

Analysis of consumer comments into PBAC decision-making (2014–9)

4 February 2022 - Our objective was to analyse and review consumer comments in the PBAC's decision-making process. ...

Read more →

Bringing a consumer perspective to clinical advice

19 October 2021 - PHARMAC is making changes to the way its advisory committees work to strengthen the input of ...

Read more →

Consumers to have more say on medicine access issues

7 September 2021 - Consumer involvement in Australia’s medicines choices has been further strengthened under a new strategic agreement Medicines ...

Read more →

How to balance the patient voice atop the shifting plates of HTA

3 August 2021 - The tectonic plates of healthcare technology assessment have shifted – but where does the patient voice ...

Read more →

Patient advocacy organisations and FDA drug approval: lessons from Aduhelm

23 July 2021 - In the wake of last month’s controversial FDA approval of Biogen’s Aduhelm, Alzheimer’s Association CEO Harry ...

Read more →

How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations

15 July 2021 - Health technology assessment agencies vary in their use of quantitative patient preference data and the extent to ...

Read more →

MHRA outlines two year delivery plan with ‘patient first’ focus

6 July 2021 - The UK’s Medicines and Healthcare products Regulatory Agency has revealed its new delivery plan, outlining its ...

Read more →

ALS association wants more commitment from the FDA

24 June 2021 - In a response letter to the ALS Association, the U.S. FDA has recognised the unmet therapeutic ...

Read more →

Moving patient stories highlight opportunities to strengthen our health care systems for all Australians

24 June 2021 - It was an emotional evening among the nearly 200 in-person and online attendees at Parliament House last ...

Read more →

How the patient voice is becoming vital for drug approval

14 June 2021 - Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a ...

Read more →

The pharma industry needs to measure patient experience from the patients’ perspectives

10 May 2021 - The relationship between clinical outcomes and the patient experience — the sum of all of interactions ...

Read more →

Patient and public involvement in health technology assessment: a new dawn?

12 April 2021 - Patient and public involvement and engagement have become increasingly embedded in health technology assessment over the last ...

Read more →

Development of an international template to support patient submissions in health technology assessments

1 April 2021 - The objective was to develop an international template to support patient submissions in health technology assessments.  ...

Read more →